BREAKING NEWS
F.D.A. Panel Declines to Endorse Alzheimer’s Drug – The New York Times
The drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. But the advisory panel said there was not enough evidence of its effectiveness in slowing cognitive decline. Click Here to Read the...
Read moreScientists say they have identified a rare gene mutation in a Colombian woman, that could be helping protect her from the onset of Alzheimer’s disease | BBC News
Click here to listen to the BBC World Service segment!
Read moreLong-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows | STAT
Just days after news that an ultra-rare form of a cholesterol-related gene called APOE protected a Colombian woman from developing early-onset Alzheimer’s disease (as one of her other genes supposedly fated her to), a second study is providing even stronger...
Read moreWhy Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease | The New York Times
A genetic mutation said she was destined to get Alzheimer’s in her 40s, just like her family members in the Colombian kindred with a rare form of the disease. But remarkably, she experienced no cognitive decline until her 70s....
Read more